Diagnosis codes capture only a fraction of the true obesity population. Measured against recorded BMI from height and weight, the majority of clinically obese patients are not identified through claims data alone, creating blind spots for patient identification, market sizing, and real-world evidence generation.
In this infographic, find out:
- How obesity diagnosis coding is undercouting the anti-obesity medication-eligible population
- Where blind spots are the greatest
- How biometric-linked data reveals the true anti-obesity medication-eligible population, not just the coded one
Download the full infographic to find out how NorstellaLinQ helps you identify the patients that diagnosis codes miss.
